[go: up one dir, main page]

AR094118A1 - Lesion renal aguda - Google Patents

Lesion renal aguda

Info

Publication number
AR094118A1
AR094118A1 ARP130104857A ARP130104857A AR094118A1 AR 094118 A1 AR094118 A1 AR 094118A1 AR P130104857 A ARP130104857 A AR P130104857A AR P130104857 A ARP130104857 A AR P130104857A AR 094118 A1 AR094118 A1 AR 094118A1
Authority
AR
Argentina
Prior art keywords
acute renal
renal injury
injury
severity
predict
Prior art date
Application number
ARP130104857A
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of AR094118A1 publication Critical patent/AR094118A1/es

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271Specific aspects of physiological measurement analysis
    • A61B5/7275Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/70Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving creatine or creatinine
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4703Regulators; Modulating activity
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475Assays involving growth factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52Assays involving cytokines
    • G01N2333/54Interleukins [IL]
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/775Apolipopeptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81Protease inhibitors
    • G01N2333/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/8139Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/24Immunology or allergic disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/34Genitourinary disorders
    • G01N2800/347Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/60Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Data Mining & Analysis (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Databases & Information Systems (AREA)
  • Physiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Signal Processing (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Veterinary Medicine (AREA)
  • Artificial Intelligence (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)

Abstract

La presente se refiere a un método para predecir la gravedad de lesión renal aguda después de cirugía cardíaca. Kit diagnóstico. Dispositivo.
ARP130104857A 2012-12-20 2013-12-18 Lesion renal aguda AR094118A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261740303P 2012-12-20 2012-12-20

Publications (1)

Publication Number Publication Date
AR094118A1 true AR094118A1 (es) 2015-07-08

Family

ID=49885245

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130104857A AR094118A1 (es) 2012-12-20 2013-12-18 Lesion renal aguda

Country Status (20)

Country Link
US (1) US20150309052A1 (es)
EP (1) EP2936160A1 (es)
JP (2) JP6416778B2 (es)
KR (1) KR20150096728A (es)
CN (1) CN104871004A (es)
AR (1) AR094118A1 (es)
AU (2) AU2013360685A1 (es)
BR (1) BR112015014232A2 (es)
CA (1) CA2895096A1 (es)
CL (1) CL2015001768A1 (es)
HK (1) HK1209838A1 (es)
IL (1) IL239431A0 (es)
MA (1) MA38171B1 (es)
MX (1) MX2015008108A (es)
PH (1) PH12015501399A1 (es)
RU (1) RU2015129496A (es)
SG (1) SG11201504329RA (es)
TN (1) TN2015000263A1 (es)
TW (1) TW201430347A (es)
WO (1) WO2014096110A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019037043A1 (zh) * 2017-08-24 2019-02-28 菲鹏生物股份有限公司 急性肾损伤的检测试剂盒
CN108986915B (zh) * 2018-07-24 2021-07-06 戴松世 人工智能的急性肾损伤的早期预测方法和装置
WO2020064995A1 (en) * 2018-09-28 2020-04-02 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of biomarkers representing cardiac, vascular and inflammatory pathways for the prediction of acute kidney injury in patients with type 2 diabetes
KR20200042725A (ko) 2018-10-16 2020-04-24 (주) 솔 렌즈 프리 cmos 광자 어레이 센서의 노이즈 특성 평가 방법
WO2020251833A1 (en) * 2019-06-11 2020-12-17 The Regents Of The University Of California Systems and methods for machine learning-based identification of acute kidney injury in trauma surgery and burned patients
CN110441457A (zh) * 2019-08-02 2019-11-12 深圳市绿航星际太空科技研究院 一种检测尿液中同型半胱氨酸的方法
CN112114125A (zh) * 2020-08-27 2020-12-22 中国医学科学院北京协和医院 一种评估肾脏储备功能的方法和系统及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60116889T2 (de) * 2000-10-17 2006-09-14 Besst-Test Aps Test zum direkten nachweis eines inflammatorischen anzeigers ein einer körperflüssigkeitsprobe
DK1340086T3 (da) * 2000-10-17 2008-12-01 Besst Test Aps Assay til direkte detektion af en RS-virusrelateret biologisk celle i en legemsvæskepröve
US20040063160A1 (en) * 2000-10-17 2004-04-01 Lassen Michael Rud Assay for directly detecting a biological cell in a body fluid sample
US20090238812A1 (en) * 2008-03-18 2009-09-24 Biotrin Intellectual Properties Limited Method for the early indentification and prediction of an abrupt reduction in kidney function in a patient undergoing cardiothoracic surgery
BRPI0922021A2 (pt) * 2008-11-10 2019-09-24 Astute Medical Inc método para avaliar a condição renal em um indivíduo, e, uso de um ou mais marcadores de lesão renal
WO2010057184A2 (en) * 2008-11-17 2010-05-20 The Brigham And Women's Hospital, Inc. Methods for detection of acute kidney injury in humans
KR101939964B1 (ko) * 2008-11-21 2019-01-18 퓨처 메디칼 다이아그노스틱스 코 엘티디 급성 신장 손상의 발견 또는 감시 방법, 장치 및 키트
CN101706497A (zh) * 2009-11-05 2010-05-12 武汉三鹰生物技术有限公司 人tff3的elisa检测试剂盒
EP2496942B1 (en) * 2009-11-07 2017-03-22 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2011250940B2 (en) * 2010-05-10 2016-02-25 Austin Health Markers for acute kidney injury
EP2661620A4 (en) * 2011-01-08 2014-07-16 Astute Medical Inc METHOD AND COMPOSITIONS FOR DIAGNOSING AND PROGNOSING RENAL INJURY AND RENAL INSUFFICIENCY

Also Published As

Publication number Publication date
HK1209838A1 (en) 2016-04-08
JP2019053067A (ja) 2019-04-04
MX2015008108A (es) 2015-11-06
IL239431A0 (en) 2015-07-30
CN104871004A (zh) 2015-08-26
TW201430347A (zh) 2014-08-01
JP6416778B2 (ja) 2018-10-31
WO2014096110A1 (en) 2014-06-26
AU2013360685A1 (en) 2015-07-02
MA38171A1 (fr) 2016-11-30
EP2936160A1 (en) 2015-10-28
CL2015001768A1 (es) 2015-10-09
US20150309052A1 (en) 2015-10-29
AU2017232081A1 (en) 2017-10-12
CA2895096A1 (en) 2014-06-26
JP2016503162A (ja) 2016-02-01
KR20150096728A (ko) 2015-08-25
PH12015501399A1 (en) 2015-09-07
MA38171B1 (fr) 2017-07-31
RU2015129496A (ru) 2017-01-26
SG11201504329RA (en) 2015-07-30
TN2015000263A1 (fr) 2016-10-03
BR112015014232A2 (pt) 2017-07-11

Similar Documents

Publication Publication Date Title
AR094118A1 (es) Lesion renal aguda
MA42238A (fr) Procédés de diagnostic du cancer de la vessie
EP3084419C0 (en) ADVANCED ULTRASONIC INSPECTION
EP3589214C0 (en) BIOPSY SYSTEM FOR IMPROVED TISSUE COLLECTION
EP2719338A4 (en) ULTRASOUND ENDOSCOPE
IL239961B (en) Diagnostically useful results in real time
IL240310A0 (en) A non-invasive diagnostic method for the diagnosis of bladder cancer
BR112014004389A2 (pt) métodos e composições para diagnóstico de lesão renal e insuficiência renal
BR112014031335A2 (pt) bloco de diagnóstico transacional
CO6930321A2 (es) Curación de tejidos
EP2909301A4 (en) STERILIZABLE PHOTOPOLYMER SERUM SUBARATOR
EP2967507A4 (en) TISSUE TREATMENT DEVICE FOR A CATHETER
EP2641542A4 (en) ULTRASOUND ENDOSCOPE
EP2623033A4 (en) ULTRASOUND DIAGNOSTIC TOOL
EP3009840A4 (en) KIT FOR IMMUNOCHROMATOGRAPHIC DIAGNOSIS
EP2887885A4 (en) FABRIC FIXING DEVICE
BR112014016493A8 (pt) sinalização slit-robo para diagnóstico e tratamendo de doença renal
EP2707710A4 (en) CANCER DIAGNOSIS
EP2789304A4 (en) ULTRASOUND SURGICAL SYSTEM
EP2578160A4 (en) ULTRASONIC DIAGNOSTIC DEVICE
DK2872054T3 (da) Kirurgisk ultralydsmikromotor
EP2880007A4 (en) EXTRACTED POLYMER NAPHTHA COMPOUND
EP2740411A4 (en) ULTRASOUND ENDOSCOPE
EP2745380A4 (en) DIAGNOSIS FOR COMMUNICATIONS BETWEEN GESNS
ES1102507Y (es) Util desechable para orinar.

Legal Events

Date Code Title Description
FB Suspension of granting procedure